Elaia Closes €134M Fund to Back Europe's Next Generation of Breakthrough Startups

Elaia Closes €134M Fund to Back Europe’s Next Generation of Breakthrough Startups

Elaia Closes €134M Fund to Back Europe’s Next Generation of Breakthrough Startups

Elaia, a leading European venture capital firm, has closed its third deep tech seed fund, DTS3, at €134 million. This fund is developed in partnership with top European research institutions, including CNRS, INRIA, and the Max Planck Foundation.

Investing in Breakthrough Startups

DTS3 will invest between €1 million and €13 million in pre-seed and seed-stage B2B startups across Europe, focusing on computing, life sciences, and industrial innovation. The fund has already deployed capital across 11 portfolio companies, including Proxima Fusion, GetVocal, and Biophta.

These companies are working on groundbreaking technologies, such as stellarator-based fusion power plants, fully auditable conversational AI agents, and topical ophthalmic inserts. Elaia’s investment strategy is built on a partnership model that gives them early visibility into breakthrough technologies and exceptional founding teams.

Accelerating Innovation in Europe

According to Anne-Sophie Carrese, Partner at Elaia, the firm is seeing an acceleration of innovation in Europe that rivals any ecosystem in the world. With hubs emerging across the continent, European deep tech is reaching escape velocity. Elaia’s international ambition is reflected in their growing investor network and their focus on backing founders across Europe.

Xavier Lazarus, Managing Partner at Elaia, stated that DTS3 will continue deploying capital throughout 2026 across three core pillars: the future of computing, the future of industry, and the future of life sciences. With 11 investments completed and strong momentum, Elaia is eager to meet ambitious entrepreneurs building Europe’s next generation of deep tech companies.

Key Areas of Focus

  • Future of computing: AI, cybersecurity, semiconductor/photonics, quantum
  • Future of industry: physical AI, robotics, material, energy
  • Future of life sciences: biotech, digital health, medical devices

Elaia’s investment strategy is focused on supporting founders who are building innovative technologies that can transform industries and improve lives. With their third deep tech seed fund, they are well-positioned to back the next generation of breakthrough startups in Europe.

Conclusion

In conclusion, Elaia’s closure of their third deep tech seed fund, DTS3, is a significant milestone for the European startup ecosystem. With their focus on investing in breakthrough startups and accelerating innovation, Elaia is playing a crucial role in shaping the future of deep tech in Europe. As they continue to deploy capital and support ambitious entrepreneurs, we can expect to see exciting developments in the years to come.

Frequently Asked Questions

  1. What is the focus of Elaia’s third deep tech seed fund, DTS3?

    Elaia’s DTS3 fund is focused on investing in pre-seed and seed-stage B2B startups across Europe, with a focus on computing, life sciences, and industrial innovation.

  2. How much will DTS3 invest in each startup?

    DTS3 will invest between €1 million and €13 million in each startup.

  3. What are the core pillars of DTS3’s investment strategy?

    The core pillars of DTS3’s investment strategy are the future of computing, the future of industry, and the future of life sciences.

  4. How many investments has DTS3 completed so far?

    DTS3 has completed 11 investments so far.

  5. What is the significance of Elaia’s closure of their third deep tech seed fund, DTS3?

    The closure of DTS3 is a significant milestone for the European startup ecosystem, as it demonstrates Elaia’s commitment to investing in breakthrough startups and accelerating innovation in Europe.